AI assistant
Panacea Biotec Ltd. Capital/Financing Update 2019
62573_rns_2019-04-08_cd636a15-9772-4154-a912-ef1cc62740d6.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
April 08, 2019
The Manager, Listing Department The National Stock Exchange ofIndia Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: PANACEABIO
BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349
- Sub.: Allotment of 71,11,111 convertible warrants on preferential basis under the provisions of Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("ICDR Regulations") and Section 42 of Companies Act, 2013
- Re: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir / Madam,
In continuation to our earlier communication dated February 26, 2019 and pursuant to the approval of shareholders obtained on March 25, 2019, we would like to inform you that the Executive Committee of the Board of Directors of the Company today has issued and allotted 71, II, III (Seventy One Lakhs Eleven Thousand One Hundred Eleven Only) convertible warrants at a price of Rs.180/- each on a preferential basis to entities as mentioned in Annexure - 1 ("Investors"), entitling them to subscribe to an equivalent number of equity shares of face value of Re.l/- each at a premium of Rs.179/- per share as per the provisions of Chapter V of ICDR Regulations.
The warrant holders shall be entitled to exercise the warrants to subscribe to equity shares of the Company in compliance with the ICDR Regulations and the agreement between the Company and the Investors.
The Company has received the upfront payment of Rs.32,OO,OO,OOO/(Rupees - Thirty Two Crore only) which is equivalent to the 25% of total consideration as per terms of preferential issue. Since the Company has allotted warrants, there is no change in the paid up equity share capital of the Company.
This is for your kind information and record please.
Thanking you,
Encl. As Above
B1 Extn. IG3, Mohan Co-op Indl. Estate, Mathura Road, New Delhi -110044 Email: [email protected] Phone: D.I.D. +91-11-41679015 Fax: +91-11-4167 9070
Panacea Biotec Ltd.
CIN:L33117PB1984PLC022350 Registered Office: Ambala-Chandigarh Highway, Lalru - 140 501, Punjab, India. Ph.:+91-1762-505900, Fax:+91-1762-505906. e-mail: [email protected] website: www.panaceabiotec.com
Annexure - t
| S. No. | Name(s)of Allottee | Numberof Warrantsallotted |
|---|---|---|
| I. | India ResurgenceFund - SchemeI | 9,95,556 |
| 2. | India ResurgenceFund - Scheme 2 | 51,20,000 |
| 3. | Piramal EnterprisesLimited | 9,95,555 |
| Total | 7t,tl,ltt |
